ASTS
AST SpaceMobile, Inc.
ASTS has slightly lower modeled downside risk, despite its lower overall score.
MRDN
Meridian Holdings Inc.
MRDN has the edge over ASTS overall, supported by stronger modeled upside.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
MRDN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Unavailable | |
| Strong |
MRDN's balance sheet is currently strong, and its revenue is stable, but its profitability is weak. There isn't enough data to rate its cash flow.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
MRDN PE Valuation
MRDN has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
MRDN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect MRDN's earnings to grow and its profitability to improve, with its revenue holding steady.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS has the edge over MRDN on earnings, with more consistent year-over-year improvement.
MRDN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.01 | — |
| Q3 2026 | -$8.10 | -$7.53 |
| Q2 2026 | -$7.05 | -$6.12 |
| Q1 2026 | -$7.58 | -$7.01 |
| Q4 2025 | -$7.76 | -$7.76 |
| Q3 2025 | -$0.57 | -371% |
| Q2 2025 | -$0.93 | -215% |
| Q1 2025 | -$0.57 | -227% |
| Q4 2024 | $0.00 | +$0.24 |
MRDN lost $8.10 per share over the past year, a bigger loss than the year before.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over MRDN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
MRDN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $46M | -2.9% |
| Q2 2026 | $50.2M | +16% |
| Q1 2026 | $50.1M | +17% |
| Q4 2025 | $49.6M | +8.1% |
| Q3 2025 | $47.3M | +15% |
| Q2 2025 | $43.2M | +9.7% |
| Q1 2025 | $42.7M | +33% |
| Q4 2024 | $45.9M | +287% |
MRDN's revenue is growing: $46M last quarter, down 2.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -32% | -32 points |
| Q2 2026 | 4.9% | +10 points |
| Q1 2026 | 6.3% | +6.5 points |
| Q4 2025 | -188% | -188 points |
| Q3 2025 | -0.8% | +1.6 points |
| Q2 2025 | -5.3% | -5.7 points |
| Q1 2025 | -0.3% | -6.2 points |
| Q4 2024 | -0.2% | -2.6 points |
MRDN has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
MRDN has the stronger cash trend. Its trailing FCF is up 164% versus its history, compared with ASTS at down 363%.
MRDN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3M | -30% |
| Q1 2026 | $5.2M | -22% |
| Q4 2025 | $6.4M | -52% |
| Q3 2025 | $6.2M | +168% |
| Q1 2025 | $6.6M | +88% |
| Q4 2024 | $13.4M | +201194% |
| Q3 2024 | $2.3M | +101% |
| Q1 2024 | $3.5M | +778% |
MRDN generated $22M in free cash flow over the past year, about the same as the year before.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
MRDN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.7% | -84.8K shares |
| 1 year | +6.5% | +778K shares |
| 3 years | +329% | +9.7M shares |
| 5 years | +550% | +10.7M shares |
| Available history | +446% | +10.4M shares |
MRDN has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $104.9M |
| Q3 2025 | — |
| Q4 2024 | $121,430 |
| Q1 2024 | — |
| Q4 2023 | — |
| Q4 2021 | — |
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MRDN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -0.3x | Net Cash |
| Q2 2025 | 1.6x | Healthy |
| Q1 2025 | -0.2x | Net Cash |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.6x | Net Cash |
| Q2 2024 | -0.9x | Net Cash |
| Q1 2024 | -4.1x | Net Cash |
| Q1 2024 | -32.8x | Net Cash |
MRDN has more cash than debt.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
MRDN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.5 | Oversold |
| Stochastic | 2.4 | Oversold |
MRDN's weekly RSI is 28 (oversold) and its Stochastic is 2 (oversold).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
MRDN PE vs Technology Sector
| Metric | MRDN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
MRDN has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has the edge over MRDN on trend strength, trading above more of its moving averages.
MRDN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.3 | 44% below |
| 20 week MA | $12.3 | 53% below |
| 50 week MA | $10.6 | 45% below |
| 100 week MA | $14.8 | 61% below |
| 200 week MA | $23.9 | 76% below |
MRDN is in a downtrend: it's below all five of its weekly moving averages, and 76% below its 200-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
MRDN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.92 | $84.8 | +971% |
| 2021 | $84.8 | $79.6 | -6.2% |
| 2022 | $79.6 | $29.6 | -63% |
| 2023 | $29.6 | $28.9 | -2.4% |
| 2024 | $28.9 | $24.5 | -15% |
| 2025 | $24.5 | $9.84 | -60% |
| 2026 YTD | $9.84 | $5.77 | -41% |
MRDN has the edge over ASTS on returns for 2026, with the stronger performance.